BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26873010)

  • 1. Ex vivo comparison of angioscopy and histopathology for the evaluation of coronary plaque characteristics.
    Shibuya M; Fujii K; Hao H; Imanaka T; Fukunaga M; Miki K; Tamaru H; Nakata T; Sawada H; Naito Y; Hirota S; Masuyama T
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):863-9. PubMed ID: 26873010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographic association of angioscopic yellow plaques with coronary atherosclerotic plaque: assessment with quantitative colorimetry in human coronary artery autopsy specimens.
    Ishibashi F; Lisauskas JB; Kawamura A; Waxman S
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):1-5. PubMed ID: 17525866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between plaque vulnerability of aorta and coronary artery: an evaluation of plaque activity by direct visualization with angioscopy.
    Aono J; Ikeda S; Katsumata Y; Higashi H; Ohshima K; Ishibashi K; Matsuoka H; Watanabe K; Hamada M
    Int J Cardiovasc Imaging; 2015 Aug; 31(6):1107-14. PubMed ID: 25916323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive Value of Integrated Backscatter IVUS for Detection of Vulnerable Plaque by Optical Frequency Domain Imaging: An Ex Vivo Autopsy Study of Human Coronary Arteries.
    Nakano M; Yahagi K; Yamamoto H; Taniwaki M; Otsuka F; Ladich ER; Joner M; Virmani R
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):163-72. PubMed ID: 26777223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between thin cap fibroatheroma identified by virtual histology and angioscopic yellow plaque in quantitative analysis with colorimetry.
    Yamamoto M; Takano M; Okamatsu K; Murakami D; Inami S; Xie Y; Seimiya K; Ohba T; Seino Y; Mizuno K
    Circ J; 2009 Mar; 73(3):497-502. PubMed ID: 19151504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of vulnerable coronary plaques by color fluorescent angioscopy.
    Uchida Y; Uchida Y; Kawai S; Kanamaru R; Sugiyama Y; Tomaru T; Maezawa Y; Kameda N
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):398-408. PubMed ID: 20394902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics.
    Takano M; Jang IK; Inami S; Yamamoto M; Murakami D; Okamatsu K; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2008 Feb; 101(4):471-6. PubMed ID: 18312760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-Infrared Spectroscopy Enhances Intravascular Ultrasound Assessment of Vulnerable Coronary Plaque: A Combined Pathological and In Vivo Study.
    Puri R; Madder RD; Madden SP; Sum ST; Wolski K; Muller JE; Andrews J; King KL; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nissen SE; Virmani R; Maehara A; Mintz GS; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2423-31. PubMed ID: 26338299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruptured plaque and large plaque burden are risks of distal embolisation during percutaneous coronary intervention: evaluation by angioscopy and virtual histology intravascular ultrasound imaging.
    Matsuo K; Ueda Y; Tsujimoto M; Hao H; Nishio M; Hirata A; Asai M; Nemoto T; Murakami A; Kashiwase K; Kodama K
    EuroIntervention; 2013 Jun; 9(2):235-42. PubMed ID: 23793009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Validation of the Coronary Angioscopic Yellow Plaque with Lipid Core Burden Index Assessed by Intracoronary Near-Infrared Spectroscopy.
    Omatsu T; Sotomi Y; Kobayashi T; Hamanaka Y; Hirata A; Hirayama A; Ueda Y; Sakata Y; Higuchi Y
    J Atheroscler Thromb; 2022 Mar; 29(3):362-369. PubMed ID: 33487618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of angioscopy and histopathology for the evaluation of carotid plaque characteristics: an ex vivo validation study.
    Kawai K; Fujii K; Shirakawa M; Uchida K; Yamada K; Kawakami R; Imanaka T; Hao H; Hirota S; Ishihara M; Yoshimura S
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):231-239. PubMed ID: 31664681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of plaque color classification for assessing plaque vulnerability: a coronary angioscopy and optical coherence tomography investigation.
    Kubo T; Imanishi T; Takarada S; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Kitabata H; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Interv; 2008 Feb; 1(1):74-80. PubMed ID: 19393149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes.
    Wykrzykowska JJ; Mintz GS; Garcia-Garcia HM; Maehara A; Fahy M; Xu K; Inguez A; Fajadet J; Lansky A; Templin B; Zhang Z; de Bruyne B; Weisz G; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S10-8. PubMed ID: 22421223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary atherosclerosis and risk of acute coronary syndromes in chronic kidney disease using angioscopy and the kidney disease: Improving Global Outcomes (KDIGO) classification.
    Kurihara O; Okamatsu K; Mizuno K; Takano M; Yamamoto M; Kobayashi N; Munakata R; Murakami D; Inami S; Ohba T; Hata N; Seino Y; Shimizu W
    Atherosclerosis; 2015 Dec; 243(2):567-72. PubMed ID: 26536302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
    Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
    Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound.
    Hirayama A; Saito S; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Nanto S; Takazawa K; Kodama K
    Circ J; 2011; 75(6):1448-54. PubMed ID: 21502706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque characterization and atherosclerosis evaluation by coronary angioscopy.
    Ueda Y; Hirayama A; Kodama K
    Herz; 2003 Sep; 28(6):501-4. PubMed ID: 14569391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of plaque vulnerability by angioscopic classification of plaque color.
    Ueda Y; Ohtani T; Shimizu M; Hirayama A; Kodama K
    Am Heart J; 2004 Aug; 148(2):333-5. PubMed ID: 15309005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study.
    Bourantas CV; Garcia-Garcia HM; Farooq V; Maehara A; Xu K; Généreux P; Diletti R; Muramatsu T; Fahy M; Weisz G; Stone GW; Serruys PW
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1263-72. PubMed ID: 24269259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy).
    Ueda Y; Matsuo K; Nishimoto Y; Sugihara R; Hirata A; Nemoto T; Okada M; Murakami A; Kashiwase K; Kodama K
    JACC Cardiovasc Interv; 2015 May; 8(6):814-821. PubMed ID: 25999104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.